Response to: '"MAINRITSAN2-the future", with some doubts!' by Chattopadhyay et al

Pierre Charles^{1

2}, Loic Guillevin³

Affiliations

¹ Department of Internal Medicine, Referral Center for Rare Systemic and Autoimmune Diseases: Vasculitis and Scleroderma, Cochin Hospital, Paris Descartes University, Paris, France.
² Department of Internal Medicine, Institut Mutualiste Montsouris, Paris, France.
³ Department of Internal Medicine, Referral Center for Rare Systemic and Autoimmune Diseases: Vasculitis and Scleroderma, Cochin Hospital, Paris Descartes University, Paris, France loic.guillevin@aphp.fr.

PMID: 30366944
DOI: 10.1136/annrheumdis-2018-214516

Comment

Response to: '"MAINRITSAN2-the future", with some doubts!' by Chattopadhyay et al

Pierre Charles et al. Ann Rheum Dis. 2019 Dec.

. 2019 Dec;78(12):e140.

doi: 10.1136/annrheumdis-2018-214516. Epub 2018 Oct 26.

Authors

Pierre Charles^{1

2}, Loic Guillevin³

Affiliations

¹ Department of Internal Medicine, Referral Center for Rare Systemic and Autoimmune Diseases: Vasculitis and Scleroderma, Cochin Hospital, Paris Descartes University, Paris, France.
² Department of Internal Medicine, Institut Mutualiste Montsouris, Paris, France.
³ Department of Internal Medicine, Referral Center for Rare Systemic and Autoimmune Diseases: Vasculitis and Scleroderma, Cochin Hospital, Paris Descartes University, Paris, France loic.guillevin@aphp.fr.

PMID: 30366944
DOI: 10.1136/annrheumdis-2018-214516

No abstract available

Keywords: B cells; granulomatosis with polyangiitis; systemic vasculitis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).
Charles P, Terrier B, Perrodeau É, Cohen P, Faguer S, Huart A, Hamidou M, Agard C, Bonnotte B, Samson M, Karras A, Jourde-Chiche N, Lifermann F, Gobert P, Hanrotel-Saliou C, Godmer P, Martin-Silva N, Pugnet G, Matignon M, Aumaitre O, Viallard JF, Maurier F, Meaux-Ruault N, Rivière S, Sibilia J, Puéchal X, Ravaud P, Mouthon L, Guillevin L; French Vasculitis Study Group. Charles P, et al. Ann Rheum Dis. 2018 Aug;77(8):1143-1149. doi: 10.1136/annrheumdis-2017-212878. Epub 2018 Apr 25. Ann Rheum Dis. 2018. PMID: 29695500 Clinical Trial.
'MAINRITSAN2-the future', with some doubts!
Chattopadhyay A, Acharya N, Mishra D, Sharma V, Naidu G, Sharma A. Chattopadhyay A, et al. Ann Rheum Dis. 2019 Dec;78(12):e139. doi: 10.1136/annrheumdis-2018-214486. Epub 2018 Oct 12. Ann Rheum Dis. 2019. PMID: 30315002 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to: '"MAINRITSAN2-the future", with some doubts!' by Chattopadhyay et al

Affiliations

Response to: '"MAINRITSAN2-the future", with some doubts!' by Chattopadhyay et al

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical